Skip to main content

Table 1 Descriptive clinicopathological characteristics of non-muscle invasive bladder cancer patients treated with TURB and RERBT

From: Retrograde en bloc resection for non-muscle invasive bladder tumor can reduce the risk of seeding cancer cells into the peripheral circulation

Characteristics

TURB, n (%)

N = 9

RERBT, n (%)

N = 12

Total

p value

Age (year)

   

0.670

< 60

4 (44.4)

7 (58.3)

11

 

≥ 60

5 (55.6)

5 (41.7)

10

 

Gender

   

1.000

Male

7 (77.8)

9 (75.0)

16

 

Female

2 (22.2)

3 (25.0)

5

 

Smoking history

   

0.660

No

3 (33.3)

6 (50.0)

9

 

Yes

6 (66.7)

6 (50.0)

12

 

Pathologic stage

   

0.660

pTa

6 (66.7)

6 (50.0)

12

 

pT1

3 (33.3)

6 (50.0)

9

 

Size (mean, cm)

1.59 ± 0.68

1.88 ± 0.59

21

0.301

Grade (WHO 2014)

   

1.000

LG

7 (77.8)

10 (83.3)

17

 

HG

2 (22.2)

2 (16.7)

4

 

Operation duration (min)

   

1.000

< 60

6 (66.7)

7 (58.3)

13

 

≥ 60

3 (33.3)

5 (41.7)

8

 

Operation duration (mean, min)

45.44 ± 15.14

47.83 ± 14.90

21

0.722

Total

9 (42.9)

12 (57.1)

21

 
  1. TURB transurethral resection of the bladder, RERBT retrograde en bloc TURB, LG low grade, HG high grade